跳至主要内容
临床试验/NCT01488435
NCT01488435已完成不适用

Efficacy and Tolerance of a Follow-On Formula Fed to Children From 36-48 Months of Age

Mead Johnson Nutrition1 个研究点 分布在 1 个国家目标入组 310 人开始时间: 2011年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
310
试验地点
1
主要终点
Acute respiratory infections and diarrheal disease

研究概览

简要总结

The purpose is to determine if the consumption of study product has an effect on acute respiratory infections and/or diarrheal disease.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
36 Months 至 48 Months(Child)
性别
All
接受健康志愿者
是

入选标准

  • •Child 36-48 months of age
  • •Child is currently attending a daycare and has attended for 6 months or less
  • •Has consumed cow's milk or a cow's milk-based beverage during the 48 hours prior to randomization
  • •Signed informed consent

排除标准

  • •Child who received any food product or supplement containing probiotics or prebiotics in the 15 days prior to randomization
  • •Child with allergy to gluten or serious concurrent illness that will interfere in the general management of the child
  • •Child with diarrhea or acute respiratory infection during the 48 hours prior to randomization
  • •Child's z-score of weight for height < -3 according to World Health Organization criteria

研究组 & 干预措施

Follow-On Formula

Experimental

Powdered Follow-On Formula with added long-chain Polyunsaturated fatty acid, prebiotics, and polysaccharide

干预措施: Follow-On Formula (Dietary Supplement)

Cow's Milk

Placebo Comparator

Powdered whole cow's milk

干预措施: Cow's milk (Dietary Supplement)

结局指标

主要结局

Acute respiratory infections and diarrheal disease

时间窗: 28 weeks

次要结局

  • Allergic manifestations(28 weeks)
  • Systemic antibiotic use(28 weeks)
  • Duration of acute respiratory infection and diarrheal disease(28 weeks)
  • Changes in stool patterns(Baseline and 28 weeks)
  • Fecal immune markers(Baseline and 28 weeks)
  • Serum Ferritin status(Baseline and 28 weeks)
  • Incidence of stool parasites(Baseline and 28 weeks)
  • Growth(28 weeks)
  • Adverse events(28 weeks)
  • Acceptance of study product(28 weeks)
  • Serum immune markers(Baseline and 28 weeks)
  • Serum zinc status(Baseline and 28 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Efficacy and Tolerance of a Follow-On Formula Fed to... | 临床试验